London Global Cancer Week

Webinar details

• Topic: Understanding the global burden of cancer: Leveraging Global Burden of Disease study estimates to improve cancer outcomes
• Date: Tuesday, November 25, 2025
• Speakers:
  • Dr. Nickhill Bhakta, MD, MPH, Associate Professor, Departments of Global Pediatric Medicine, Epidemiology and Cancer Control, and Oncology at St. Jude Children’s Research Hospital
  • Lisa Force, MD, MPH, Assistant Professor, Department of Health Metrics Sciences at the University of Washington and IHME, Global Burden of Disease Study Cancer Team Lead
  • Flávia Araújo Girardi, MD, MPH, PhD, medical expert at the Federal Department of Medical Expertise of the Ministry of Social Security in Brazil
  • Dr. Awoke Misganaw, PhD, MPH, Clinical Associate Professor in the Department of Health Metrics Sciences at UW and Senior Advisor of Ethiopia’s National Data Management and Analytics Center (NDMC) at the Ethiopian Public Health Institute
  • Dr. Siti Nadia Tarmizi, M.Epid., Director of Noncommunicable Diseases, Ministry of Health of the Republic of Indonesia
  • Dr. David Watkins, MD, MPH, Associate Professor, Departments of Medicine and Global Health at the University of Washington, a PI and series editor of the Disease Control Priorities Project

Watch the recording

About the webinar

Cancer remains a leading cause of the global disease burden, and cancer cases and deaths are forecasted to rise through at least 2050, with disproportionate growth in low- and middle-income countries. Effectively tackling this global challenge will require sustained, collaborative international and national action.

Understanding the burden of cancer is essential to the development of effective strategies, but directly observed data are not available in every country. The Global Burden of Disease study (GBD) estimates cancer burden for 204 countries and territories and these results can be leveraged as part of broader policy and resource planning efforts to collectively improve cancer outcomes.

The Institute for Health Metrics and Evaluation (IHME) webinar will include:

• An overview of GBD 2023 global cancer burden estimates from 1990 to 2023, with forecasts through 2050, and the types of results available through online visualization tools.
• A panel discussion highlighting how GBD estimates have been used to address cancer burden at national and global levels.
• A discussion of approaches to applying GBD estimates toward program goals, and potential future opportunities for leveraging GBD results to address cancer burden.

Learn more about London Global Cancer Week